FDA – Page 12 – One America News Network

Video still from Emma Waters' interview with Tipping Point on One America News Network

FDA Discusses Using Artificial Wombs for Human Infants

with Emma Waters

LOS ANGELES, CALIFORNIA - APRIL 17: In this photo illustration, boxes of the diabetes drug Ozempic rest on a pharmacy counter on April 17, 2023 in Los Angeles, California. Ozempic was originally approved by the FDA to treat people with Type 2 diabetes- who risk serious health consequences without medication. In recent months, there has been a spike in demand for Ozempic, or semaglutide, due to its weight loss benefits, which has led to shortages. Some doctors prescribe Ozempic off-label to treat obesity. (Photo illustration by Mario Tama/Getty Images)

FDA Updates Ozempic, Other Drugs’ Warning Labels, Adding ‘Blocked Intestines’ As Possible Side Effect

The diabetic treatment Ozempic, which has gained popularity for not only diabetes but weight loss too, now lists clogged intestines as a side effect on the label.

Video still from Dr. Shannon Kroner's interview with In Focus on One America News Network

FDA Approves 1st RSV Vaccine for Babies

with Dr. Shannon Kroner

MIAMI, FLORIDA - SEPTEMBER 12: Cold and flu medicine sits on a store shelf on September 12, 2023 in Miami, Florida. The Food and Drug Administration (FDA) advisory panel announced that an ingredient in many over-the-counter cold and allergy medications called phenylephrine doesn’t work to get rid of nasal congestion and that the decongestant was no more effective than a placebo. (Photo by Joe Raedle/Getty Images)

FDA Panel: Decongestants In Allergy Medicines Are Ineffective

On Tuesday, the Food and Drug Administration (FDA) advisory panel announced that phenylephrine, an ingredient found in many over-the-counter cold and allergy medications, is completely ineffective.